Symbols / NEXI $0.00 +0.00% NexImmune, Inc.
NEXI Chart
About
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a vivo directly injectable modality platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It also provides NEXI-004 which is in preclinical stage for EBV related diseases. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
Stock Fundamentals
Scroll to Statements| Market Cap | 139.00 | Enterprise Value | -2.42M | Income | -20.62M | Sales | — | Book/sh | 0.50 | Cash/sh | 1.74 |
| Dividend Yield | — | Payout | 0.00% | Employees | 6 | IPO | — | P/E | — | Forward P/E | -0.00 |
| PEG | — | P/S | — | P/B | 0.00 | P/C | — | EV/EBITDA | 0.15 | EV/Sales | — |
| Quick Ratio | 0.51 | Current Ratio | 0.66 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | -18.51 | EPS next Y | -3.75 |
| EPS Growth | — | Revenue Growth | — | Earnings | 2023-08-10 | ROA | -72.69% | ROE | -232.97% | ROIC | — |
| Gross Margin | 0.00% | Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 1.39M | Shs Float | 1.18M | Short Float | 1.30% |
| Short Ratio | 2.26 | Short Interest | — | 52W High | 1.01 | 52W Low | 0.00 | Beta | 5.47 | Avg Volume | 44.00 |
| Volume | 100.00 | Target Price | — | Recom | None | Prev Close | $0.00 | Price | $0.00 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-91.63
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
- Nexi Stock Forecast 2026–2030 | Future Outlook - Capital.com Wed, 28 Jan 2026 08
- Shares in Italian Payments Group Nexi Dive After Targets Underwhelm - WSJ hu, 05 Mar 2026 08
- Shares in Italy's Nexi fall as longtime CEO steps down - Reuters hu, 26 Mar 2026 07
- Nexi shares fall as payments firm names CFO Mingrone as new CEO - Investing.com hu, 26 Mar 2026 07
- 10 Undervalued European Stocks | Morningstar Nordics - Morningstar ue, 13 Jan 2026 08
- Nexi's stock market plunges after its 2025 accounts and new plan without buybacks. A higher dividend isn't enough to support the stock. - firstonline.info hu, 05 Mar 2026 08
- Assessing Nexi's (BIT:NEXI) Valuation: Is the Market Overlooking Its Potential? - Yahoo Finance Wed, 24 Sep 2025 07
- Nexi outlines plan to tackle payments sector challenges as shares plunge - Reuters hu, 05 Mar 2026 08
- Weighing Nexi’s Value After Five Year 70% Slide and M&A Speculation in 2025 - webull.com Wed, 24 Sep 2025 07
- Milan stock market slides as oil prices surge; banks drag while Nexi attempts rally - marketscreener.com Mon, 09 Mar 2026 07
- Nexi plunges close to record lows after cautious FY margin outlook - TradingView Wed, 05 Nov 2025 08
- Nexi’s New Plan Didn’t Stop A 20% Stock Drop - Finimize hu, 05 Mar 2026 09
- Weighing Nexi’s Value After Five Year 70% Slide and M&A Speculation in 2025 - simplywall.st Wed, 24 Sep 2025 07
- BofA cuts Nexi stock rating on weak results, softer outlook - Investing.com Fri, 06 Mar 2026 08
- Nexi's stock market performance is positive, but its cautious outlook on margins is sinking its shares. - firstonline.info Wed, 05 Nov 2025 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
32.28
-48.82%
|
63.08
+18.45%
|
53.26
|
| Research And Development |
|
19.28
-59.10%
|
47.15
+25.88%
|
37.46
|
| Selling General And Administration |
|
13.00
-18.41%
|
15.93
+0.85%
|
15.80
|
| General And Administrative Expense |
|
13.00
-18.41%
|
15.93
+0.85%
|
15.80
|
| Other Gand A |
|
13.00
-18.41%
|
15.93
+0.85%
|
15.80
|
| Total Expenses |
|
32.28
-48.82%
|
63.08
+18.45%
|
53.26
|
| Operating Income |
|
-32.28
+48.82%
|
-63.08
-18.45%
|
-53.26
|
| Total Operating Income As Reported |
|
-32.97
+47.73%
|
-63.08
-18.45%
|
-53.26
|
| EBITDA |
|
-31.26
+49.66%
|
-62.09
-26.39%
|
-49.13
|
| Normalized EBITDA |
|
-30.57
+50.77%
|
-62.09
-18.50%
|
-52.39
|
| Reconciled Depreciation |
|
1.02
+3.03%
|
0.99
+14.31%
|
0.87
|
| EBIT |
|
-32.28
+48.82%
|
-63.08
-26.18%
|
-50.00
|
| Total Unusual Items |
|
-0.69
|
0.00
-100.00%
|
3.27
|
| Total Unusual Items Excluding Goodwill |
|
-0.69
|
0.00
-100.00%
|
3.27
|
| Special Income Charges |
|
-0.69
|
0.00
-100.00%
|
0.84
|
| Other Special Charges |
|
—
|
—
|
-0.84
|
| Net Income |
|
-32.34
+48.25%
|
-62.51
-22.80%
|
-50.90
|
| Pretax Income |
|
-32.34
+48.25%
|
-62.51
-22.80%
|
-50.90
|
| Net Non Operating Interest Income Expense |
|
0.70
+5.12%
|
0.66
+177.90%
|
-0.85
|
| Interest Expense Non Operating |
|
—
|
0.00
-100.00%
|
0.91
|
| Net Interest Income |
|
0.70
+5.12%
|
0.66
+177.90%
|
-0.85
|
| Interest Expense |
|
—
|
0.00
-100.00%
|
0.91
|
| Interest Income Non Operating |
|
0.70
+5.12%
|
0.66
+1165.21%
|
0.05
|
| Interest Income |
|
0.70
+5.12%
|
0.66
+1165.21%
|
0.05
|
| Other Income Expense |
|
-0.76
-766.69%
|
-0.09
-102.73%
|
3.21
|
| Other Non Operating Income Expenses |
|
-0.07
+21.12%
|
-0.09
-42.79%
|
-0.06
|
| Gain On Sale Of Security |
|
—
|
—
|
2.42
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-32.34
+48.25%
|
-62.51
-22.80%
|
-50.90
|
| Net Income From Continuing Operation Net Minority Interest |
|
-32.34
+48.25%
|
-62.51
-22.80%
|
-50.90
|
| Net Income From Continuing And Discontinued Operation |
|
-32.34
+48.25%
|
-62.51
-22.80%
|
-50.90
|
| Net Income Continuous Operations |
|
-32.34
+48.25%
|
-62.51
-22.80%
|
-50.90
|
| Normalized Income |
|
-31.65
+49.36%
|
-62.51
-15.39%
|
-54.17
|
| Net Income Common Stockholders |
|
-32.34
+48.25%
|
-62.51
-21.89%
|
-51.28
|
| Diluted EPS |
|
-30.82
+52.58%
|
-65.00
-2.36%
|
-63.50
|
| Basic EPS |
|
-30.82
+52.58%
|
-65.00
-2.36%
|
-63.50
|
| Basic Average Shares |
|
1.05
+9.05%
|
0.96
+19.19%
|
0.81
|
| Diluted Average Shares |
|
1.05
+9.05%
|
0.96
+19.19%
|
0.81
|
| Diluted NI Availto Com Stockholders |
|
-32.34
+48.25%
|
-62.51
-21.89%
|
-51.28
|
| Gain On Sale Of PPE |
|
-0.69
|
0.00
|
—
|
| Preferred Stock Dividends |
|
—
|
—
|
0.38
|
| Line Item | Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Assets |
|
8.59
-80.04%
|
43.06
-52.70%
|
91.03
|
| Current Assets |
|
5.40
-85.55%
|
37.37
-56.69%
|
86.28
|
| Cash Cash Equivalents And Short Term Investments |
|
4.65
-86.59%
|
34.64
-57.66%
|
81.82
|
| Cash And Cash Equivalents |
|
3.20
-90.76%
|
34.64
+14.23%
|
30.33
|
| Cash Equivalents |
|
—
|
—
|
27.62
|
| Cash Financial |
|
—
|
—
|
2.70
|
| Other Short Term Investments |
|
1.44
|
0.00
-100.00%
|
51.49
|
| Receivables |
|
0.00
-100.00%
|
0.07
|
0.00
|
| Accrued Interest Receivable |
|
0.00
-100.00%
|
0.07
|
0.00
|
| Prepaid Assets |
|
0.52
-76.35%
|
2.20
-48.90%
|
4.30
|
| Restricted Cash |
|
0.02
-63.64%
|
0.06
-18.52%
|
0.07
|
| Other Current Assets |
|
0.22
-46.45%
|
0.40
+305.20%
|
0.10
|
| Total Non Current Assets |
|
3.19
-43.89%
|
5.69
+19.78%
|
4.75
|
| Net PPE |
|
1.40
-74.21%
|
5.43
+22.56%
|
4.43
|
| Gross PPE |
|
2.95
-65.87%
|
8.66
+29.03%
|
6.71
|
| Accumulated Depreciation |
|
-1.55
+51.86%
|
-3.23
-41.58%
|
-2.28
|
| Properties |
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.20
-64.07%
|
0.56
+5.64%
|
0.53
|
| Other Properties |
|
2.71
-65.06%
|
7.77
+30.75%
|
5.94
|
| Leases |
|
0.04
-88.60%
|
0.32
+38.96%
|
0.23
|
| Other Non Current Assets |
|
1.79
+576.82%
|
0.26
-18.24%
|
0.32
|
| Total Liabilities Net Minority Interest |
|
5.08
-52.75%
|
10.76
+47.97%
|
7.27
|
| Current Liabilities |
|
5.08
-50.80%
|
10.33
+43.21%
|
7.22
|
| Payables And Accrued Expenses |
|
5.02
-48.48%
|
9.73
+34.90%
|
7.22
|
| Payables |
|
1.34
-43.79%
|
2.38
+127.47%
|
1.05
|
| Accounts Payable |
|
1.34
-43.79%
|
2.38
+127.47%
|
1.05
|
| Current Accrued Expenses |
|
3.68
-49.99%
|
7.36
+19.23%
|
6.17
|
| Current Debt And Capital Lease Obligation |
|
0.07
-88.51%
|
0.60
|
—
|
| Current Capital Lease Obligation |
|
0.07
-88.51%
|
0.60
|
0.00
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
-100.00%
|
0.43
+666.03%
|
0.06
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
-100.00%
|
0.43
|
0.00
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
0.43
|
0.00
|
| Non Current Deferred Liabilities |
|
—
|
0.00
-100.00%
|
0.06
|
| Stockholders Equity |
|
3.51
-89.13%
|
32.30
-61.44%
|
83.76
|
| Common Stock Equity |
|
3.51
-89.13%
|
32.30
-61.44%
|
83.76
|
| Capital Stock |
|
0.00
+1.46%
|
0.00
+14.24%
|
0.00
|
| Common Stock |
|
0.00
+1.46%
|
0.00
+14.24%
|
0.00
|
| Share Issued |
|
1.07
+2.22%
|
1.04
+14.23%
|
0.91
|
| Ordinary Shares Number |
|
1.07
+2.22%
|
1.04
+14.23%
|
0.91
|
| Additional Paid In Capital |
|
226.10
+1.60%
|
222.55
+5.22%
|
211.50
|
| Retained Earnings |
|
-222.59
-17.00%
|
-190.25
-48.93%
|
-127.74
|
| Gains Losses Not Affecting Retained Earnings |
|
—
|
0.00
-100.00%
|
0.00
|
| Other Equity Adjustments |
|
—
|
—
|
0.00
|
| Total Equity Gross Minority Interest |
|
3.51
-89.13%
|
32.30
-61.44%
|
83.76
|
| Total Capitalization |
|
3.51
-89.13%
|
32.30
-61.44%
|
83.76
|
| Working Capital |
|
0.32
-98.83%
|
27.04
-65.81%
|
79.06
|
| Invested Capital |
|
3.51
-89.13%
|
32.30
-61.44%
|
83.76
|
| Total Debt |
|
0.07
-93.29%
|
1.02
|
0.00
|
| Capital Lease Obligations |
|
0.07
-93.29%
|
1.02
|
0.00
|
| Net Tangible Assets |
|
3.51
-89.13%
|
32.30
-61.44%
|
83.76
|
| Tangible Book Value |
|
3.51
-89.13%
|
32.30
-61.44%
|
83.76
|
| Line Item | Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow |
|
-31.43
+38.60%
|
-51.19
-11.81%
|
-45.79
|
| Cash Flow From Continuing Operating Activities |
|
-31.43
+38.60%
|
-51.19
-11.81%
|
-45.79
|
| Net Income From Continuing Operations |
|
-32.34
+48.25%
|
-62.51
-22.80%
|
-50.90
|
| Depreciation Amortization Depletion |
|
1.02
+3.03%
|
0.99
+14.31%
|
0.87
|
| Depreciation And Amortization |
|
1.02
+3.03%
|
0.99
+14.31%
|
0.87
|
| Other Non Cash Items |
|
0.54
+7.36%
|
0.50
-44.62%
|
0.90
|
| Stock Based Compensation |
|
3.55
-39.46%
|
5.87
-1.83%
|
5.98
|
| Operating Gains Losses |
|
0.68
+3080.38%
|
0.02
+100.65%
|
-3.26
|
| Gain Loss On Investment Securities |
|
—
|
—
|
-2.42
|
| Change In Working Capital |
|
-4.88
-224.15%
|
3.93
+500.31%
|
0.65
|
| Change In Prepaid Assets |
|
1.95
+12.96%
|
1.72
+183.92%
|
-2.05
|
| Change In Payables And Accrued Expense |
|
-4.72
-278.58%
|
2.65
-12.09%
|
3.01
|
| Change In Accrued Expense |
|
-3.68
-392.72%
|
1.26
-68.64%
|
4.01
|
| Change In Payable |
|
-1.04
-175.06%
|
1.39
+238.31%
|
-1.00
|
| Change In Account Payable |
|
-1.04
-175.06%
|
1.39
+238.31%
|
-1.00
|
| Change In Other Current Assets |
|
-1.53
-2684.86%
|
0.06
+119.66%
|
-0.30
|
| Change In Other Current Liabilities |
|
-0.57
-15.00%
|
-0.50
|
0.00
|
| Investing Cash Flow |
|
-0.04
-100.09%
|
50.32
+193.51%
|
-53.81
|
| Cash Flow From Continuing Investing Activities |
|
-0.04
-100.09%
|
50.32
+193.51%
|
-53.81
|
| Net PPE Purchase And Sale |
|
-0.04
+96.21%
|
-1.17
+50.04%
|
-2.35
|
| Purchase Of PPE |
|
-0.05
+96.12%
|
-1.26
+46.60%
|
-2.35
|
| Sale Of PPE |
|
0.00
-94.77%
|
0.08
|
0.00
|
| Capital Expenditure |
|
-0.05
+96.12%
|
-1.26
+46.60%
|
-2.35
|
| Net Investment Purchase And Sale |
|
0.00
-100.00%
|
51.49
+200.06%
|
-51.46
|
| Purchase Of Investment |
|
0.00
+100.00%
|
-21.51
+76.22%
|
-90.46
|
| Sale Of Investment |
|
0.00
-100.00%
|
73.00
+87.18%
|
39.00
|
| Financing Cash Flow |
|
0.00
-100.00%
|
5.18
-95.85%
|
124.89
|
| Cash Flow From Continuing Financing Activities |
|
0.00
-100.00%
|
5.18
-95.85%
|
124.89
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
-100.00%
|
9.02
|
| Issuance Of Debt |
|
—
|
0.00
-100.00%
|
9.03
|
| Repayment Of Debt |
|
—
|
0.00
+100.00%
|
-0.01
|
| Long Term Debt Issuance |
|
—
|
0.00
-100.00%
|
9.03
|
| Long Term Debt Payments |
|
—
|
0.00
+100.00%
|
-0.01
|
| Net Long Term Debt Issuance |
|
—
|
0.00
-100.00%
|
9.02
|
| Net Common Stock Issuance |
|
0.00
-100.00%
|
5.15
-95.51%
|
114.72
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
0.03
-97.15%
|
1.17
|
| Net Other Financing Charges |
|
—
|
—
|
-0.02
|
| Changes In Cash |
|
-31.47
-831.38%
|
4.30
-82.99%
|
25.30
|
| Beginning Cash Position |
|
34.70
+14.16%
|
30.39
+496.12%
|
5.10
|
| End Cash Position |
|
3.22
-90.71%
|
34.70
+14.16%
|
30.39
|
| Free Cash Flow |
|
-31.48
+39.98%
|
-52.45
-8.96%
|
-48.14
|
| Interest Paid Supplemental Data |
|
—
|
0.00
-100.00%
|
0.00
|
| Amortization Of Securities |
|
0.00
+100.00%
|
-0.00
+96.47%
|
-0.03
|
| Common Stock Issuance |
|
0.00
-100.00%
|
5.15
-95.51%
|
114.72
|
| Issuance Of Capital Stock |
|
0.00
-100.00%
|
5.15
-95.51%
|
114.72
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|